A- A A+

Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services. 

Croxford S, Emanuel E, Ibitoye A, Njoroge J, Edmundson C, Bardsley M, Heinsbroek E, Hope V, Phipps E. 

Public Health. 2021 Mar;192:8-11. doi: 10.1016/j.puhe.2021.01.004. Epub 2021 Jan 15. PMID: 33601307; PMCID: PMC7836733.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836733/

Responding to COVID-19: Emerging Practices in Addiction Medicine in 17 Countries. 

Scheibein F, Stowe MJ, Arya S, Morgan N, Shirasaka T, Grandinetti P, Saad NA, Ghosh A, Vadivel R, Ratta-Apha W, Pant SB, Ransing R, Ramalho R, Bruschi A, Maiti T, Ha AY, Delic M, Jain S, Peyron E, Siste K, Onoria J, Boujraf S, Dannatt L, Schellekens A, Calvey T. 

Front Psychiatry. 2021 Mar 12;12:634309. doi: 10.3389/fpsyt.2021.634309. PMID: 33796034; PMCID: PMC8009036.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009036/

Emergency department utilization for mental health conditions before and after the COVID-19 outbreak. 

Stroever S, Brett C, Michael K, Petrini J. 

Am J Emerg Med. 2021 Mar 31;47:164-168. doi: 10.1016/j.ajem.2021.03.084. Epub ahead of print. PMID: 33813148; PMCID: PMC8010358.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010358/

COVID-19: A new barrier to treatment for opioid use disorder in the emergency department. 

Grunvald W, Herrington R, King R, Lamberson M, Mackey S, Maruti S, Rawson R, Wolfson D. 

J Am Coll Emerg Physicians Open. 2021 Mar 17;2(2):e12403. doi: 10.1002/emp2.12403. PMID: 33748808; PMCID: PMC7967916.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967916/

A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19

Strathdee SA. 

Drug Alcohol Depend. 2021;108680. doi:10.1016/j.drugalcdep.2021.108680, [published online ahead of print, 2021 Mar 18]. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970788/

The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals. 

Mistler CB, Curley CM, Rosen AO, El-Krab R, Wickersham JA, Copenhaver MM, Khati A, Shrestha R. 

J Community Health. 2021 Mar 26:1–7. doi: 10.1007/s10900-021-00979-0. Epub ahead of print. PMID: 33770334; PMCID: PMC7996112.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996112/

Integrated substance use and prenatal care delivery in the era of COVID-19. 

Patton EW, Saia K, Stein MD. 

J Subst Abuse Treat. 2021 May;124:108273. doi: 10.1016/j.jsat.2020.108273. Epub 2021 Jan 2. PMID: 33771277; PMCID: PMC7979279.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979279/

Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study.

Hunter SB, Dopp AR, Ober AJ, Uscher-Pines L. 

J Subst Abuse Treat. 2021 May;124:108288. doi: 10.1016/j.jsat.2021.108288. Epub 2021 Jan 13. PMID: 33771285; PMCID: PMC7833320.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833320/

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial. 

Watson DP, Swartz JA, Robison-Taylor L, Mackesy-Amiti ME, Erwin K, Gastala N, Jimenez AD, Staton MD, Messmer S. 

BMC Public Health. 2021 Mar 31;21(1):630. doi: 10.1186/s12889-021-10669-0. PMID: 33789642; PMCID: PMC8010496.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010496/

Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. 

Clement J, Jacobi M, Greenwood BN (2021) 

PLoS ONE 16(4): e0249453. doi.org/10.1371/journal.pone.0249453

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249453

The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members. 

Dannatt L, Ransing R, Calvey T, Scheibein F, Saad NA, Shirasaka T, Ramalho R, Pant S, Vadivel R, Siste K, Stowe MJ, Kalita KN, Boujraf S, Testa R, Arya S, Morgan N, Grandinetti P. 

Front Psychiatry. 2021 Mar 2;12:634515. doi: 10.3389/fpsyt.2021.634515. PMID: 33762979; PMCID: PMC7982835.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982835/

Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic. 

Wang L, Weiss J, Ryan EB, Waldman J, Rubin S, Griffin JL. 

J Subst Abuse Treat. 2021 May;124:108272. doi: 10.1016/j.jsat.2020.108272. Epub 2021 Jan 15. PMID: 33771276; PMCID: PMC7833481.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833481/

Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island. 

Clark SA, Davis C, Wightman RS, Wunsch C, Keeler LAJ, Reddy N, Samuels EA. 

J Subst Abuse Treat. 2021 May;124:108283. doi: 10.1016/j.jsat.2021.108283. Epub 2021 Jan 20. PMID: 33771282; PMCID: PMC7817486.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817486/

EMCDDA. EMCDDA trendspotter briefing: Impact of COVID-19 on drug use and drug services in Western Balkans

Summary

The Western Balkans (Albania, Bosnia and Herzegovina, Kosovo*, Montenegro, North Macedonia and Serbia) registered the main waves of COVID-19 infections later than most of the EU countries, but containment strategies were implemented at the same time and with equal force as in the rest of Europe. This report provides the main results of studies conducted using the trendspotter methodology to explore the impact of the pandemic and associated measures on drug services and people who use drugs in the Western Balkan region.

*Kosovo: this designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence.

(EMCDDA, Lissabon, March 2021

https://www.emcdda.europa.eu/system/files/publications/13661/BriefingTS-IPA-Covid-services.pdf

Impact of Pandemics/Epidemics on Emergency Department Utilization for Mental Health and Substance Use: A Rapid Review. 

Munich J, Dennett L, Swainson J, Greenshaw AJ, Hayward J. 

Front Psychiatry. 2021 Feb 24;12:615000. doi: 10.3389/fpsyt.2021.615000. PMID: 33716818; PMCID: PMC7943839.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943839/

Notes from the Field: Opioid Overdose Deaths Before, During, and After an 11-Week COVID-19 Stay-at-Home Order - Cook County, Illinois, January 1, 2018-October 6, 2020. 

Mason M, Welch SB, Arunkumar P, Post LA, Feinglass JM.

MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):362-363. doi: 10.15585/mmwr.mm7010a3. PMID: 33705372.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7010a3.htm

COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management. 

Mehtani NJ, Ristau JT, Snyder H, Surlyn C, Eveland J, Smith-Bernardin S, Knight KR. 

Subst Abus. 2021 Mar 8:1-8. doi: 10.1080/08897077.2021.1890676. Epub ahead of print. PMID: 33684331.

Abstract

https://www.tandfonline.com/doi/abs/10.1080/08897077.2021.1890676

Another silver lining?: Anthropological perspectives on the promise and practice of relaxed restrictions for telemedicine and medication-assisted treatment in the context of COVID-19. 

Eaves E, Trotter R 2nd, Baldwin J. 

Hum Organ. 2020 Winter;79(4):292-303. doi: 10.17730/1938-3525-79.4.292. Epub 2020 Dec 2. PMID: 33551465; PMCID: PMC7861509.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861509/

Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment. 

Cole TO, Robinson D, Kelley-Freeman A, Gandhi D, Greenblatt AD, Weintraub E, Belcher AM. 

Front Public Health. 2021 Jan 21;8:557275. doi: 10.3389/fpubh.2020.557275. PMID: 33553083; PMCID: PMC7859509.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859509/

"How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic. 

Krawczyk N, Bunting AM, Frank D, Arshonsky J, Gu Y, Friedman SR, Bragg MA. 

Int J Drug Policy. 2021 Feb 5:103140. doi: 10.1016/j.drugpo.2021.103140. Epub ahead of print. PMID: 33558165.

Abstract

https://www.sciencedirect.com/science/article/abs/pii/S0955395921000384

A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access during the COVID-19 Pandemic. 

Tofighi B, McNeely J, Walzer D, Fansiwala K, Demner A, Chaudhury CS, Subudhi I, Schatz D, Reed T, Krawczyk N. 

J Addict Med. 2021 Feb 5. doi: 10.1097/ADM.0000000000000809. Epub ahead of print. PMID: 33560696.

Abstract

https://journals.lww.com/journaladdictionmedicine/Abstract/9000/A_Telemedicine_Buprenorphine_Clinic_to_Serve_New.99088.aspx

Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study. 

Oviedo-Joekes E, MacDonald S, Boissonneault C, Harper K. 

Subst Abuse Treat Prev Policy. 2021 Mar 5;16(1):22. doi: 10.1186/s13011-021-00358-x. PMID: 33673847; PMCID: PMC7935000.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935000/

Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. 

Jacka BP, Janssen T, Garner BR, Yermash J, Yap KR, Ball EL, Hartzler B, Becker SJ. 

Drug Alcohol Depend. 2021 Feb 15;221:108617. doi: 10.1016/j.drugalcdep.2021.108617. Epub ahead of print. PMID: 33647590; PMCID: PMC7883735.

https://www.sciencedirect.com/science/article/pii/S0376871621001125

Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California. 

Herring AA, Kalmin M, Speener M, Goodman-Meza D, Snyder H, Campbell A, Moulin A, Shoptaw S. 

J Subst Abuse Treat. 2021 Apr;123:108260. doi: 10.1016/j.jsat.2020.108260. Epub 2020 Dec 27. PMID: 33612194; PMCID: PMC7832157.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832157/

A chance to do it better: Methadone maintenance treatment in the age of Covid-19. 

Frank D. 

J Subst Abuse Treat. 2021 Apr;123:108246. doi: 10.1016/j.jsat.2020.108246. Epub 2020 Dec 13. PMID: 33612189; PMCID: PMC7834469.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834469/

Webinar. Opioidabhängigkeit aktuell vor dem Hintergrund der COVID19 Pandemie (Aufzeichnung, Video, 60:00)

Referenten: Prof. Jens Reimer, Dr. Thomas Poehlke

Die Veranstaltung ist von der BLÄK mit 1 CME-Punkt anerkannt

https://step-initiative.de/demand_page/video_page.html

TAKE HOME OPIATE SUBSTITUTE THERAPIES (OST) ADVOCACY BRIEF

EuroNPUD – European Network of People who use Drugs, 2020

http://www.civilsocietyforumondrugs.eu/wp-content/uploads/2021/02/Advocacy-Brief-F4.pdf

The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland. 

Genberg BL, Astemborski J, Piggott DA, Woodson-Adu T, Kirk GD, Mehta SH. 

Drug Alcohol Depend. 2021 Feb 13;221:108584. doi: 10.1016/j.drugalcdep.2021.108584. Epub ahead of print. PMID: 33607497; PMCID: PMC7881742.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881742/

Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder. 

Stringer KL, Langdon KJ, McKenzie M, Brockmann B, Marotta P. 

J Subst Abuse Treat. 2021 Apr;123:108263. doi: 10.1016/j.jsat.2020.108263. Epub 2020 Dec 26. PMID: 33612196; PMCID: PMC7900610.

Abstract

https://www.journalofsubstanceabusetreatment.com/artichttps://www.journalofsubstanceabusetreatment.com/article/S0740-5472(20)30520-1/fulltext

Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. 

Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. 

J Subst Abuse Treat. 2021 Apr;123:108276. doi: 10.1016/j.jsat.2021.108276. Epub 2021 Jan 8. PMID: 33612201.

https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(21)00002-7/fulltext(21)00002-7/fulltext